心肺MRI用于检测CTEPH患者单次BPA治疗后的治疗反应
本研究对29例CTEPH患者在心肺MRI引导下于首次BPA术前和术后62天进行心肺MRI检查,评估肺血流量(PBF)、首过团注动力学参数及双心室质量与功能。结果显示单次BPA后区域PBF在治疗肺叶和非治疗肺叶均增加,且治疗肺叶变化显著大于非治疗肺叶,提示心肺MRI可检测并量化单次BPA治疗后的治疗反应。
要点
- 单次BPA术后62天,治疗肺叶PBF较术前显著增加(p<0.0001),非治疗肺叶亦增加(p=0.015)
- 治疗肺叶PBF变化显著大于非治疗肺叶(p=0.0049)
- NT proBNP、MRI推导的mPAP、PTT、FWHM、RV射血分数、RV每搏量、CO、VMI及非治疗肺叶PBF变化与治疗肺叶PBF变化相关(p<0.05)
核心结论
- 心肺MRI可检测并量化CTEPH患者单次BPA治疗后的治疗反应。
研究设计与样本
- 研究纳入29例CTEPH患者,于首次BPA术前和术后62天行心肺MRI,测定PBF、首过团注动力学参数及双心室质量与功能;采用多元线性回归分析、配对Wilcoxon秩和检验和Spearman rho相关分析。
关键影像表现/征象
- 单次BPA术后62天,治疗肺叶PBF较术前显著增加(p<0.0001),非治疗肺叶PBF亦增加(p=0.015)。
- 治疗肺叶PBF变化显著大于非治疗肺叶(p=0.0049)。
- NT proBNP、MRI推导的mPAP、PTT、FWHM、RV射血分数、RV每搏量、CO、VMI及非治疗肺叶PBF变化与治疗肺叶PBF变化相关(p<0.05)。
- 治疗肺叶PBF变化可由PTT及非治疗肺叶PBF变化独立预测。
临床应用与阅片要点
- 心肺MRI可用于CTEPH患者单次BPA术后治疗反应的检测和量化。
- 治疗肺叶PBF变化与PTT及非治疗肺叶PBF变化独立相关,提示这些指标可能用于评估治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with balloon pulmonary angioplasty (BPA) in inoperable patients. Sensitive non-invasive imaging methods are missing to detect treatment response after a single BPA treatment session. Therefore, the aim of this study was to measure treatment response after a single BPA session using cardio-pulmonary MRI.
MATERIALS AND METHODS: Overall, 29 patients with CTEPH were examined with cardio-pulmonary MRI before and 62 days after their initial BPA session. Pulmonary blood flow (PBF), first-pass bolus kinetic parameters, and biventricular mass and function were determined. Multiple linear regression analysis was implemented to estimate the relationship of PBF change in the treated lobe with treatment change of full width at half maximum (FWHM), cardiac output (CO), ventricular mass index (VMI), pulmonary transit time (PTT) and PBF change in the non-treated lobes. Paired Wilcoxon rank sum test and Spearman rho correlation were used.
RESULTS: After BPA regional PBF increased in the treated lobe (p < 0.0001) as well as in non-treated lobes (p = 0.015). PBF treatment changes in the treated lobe were significantly larger compared with the non-treated lobes (p = 0.0049). Change in NT proBNP, MRI-derived mean pulmonary artery pressure (mPAP), PTT, FWHM, right ventricular (RV) ejection fraction, RV stroke volume, CO, VMI and PBF in the non-treated lobes correlated with PBF change in the treated lobe (p < 0.05). PBF changes in the treated lobe were independently predicted by PTT as well as PBF change in the non-treated lobes.
CONCLUSION: Cardio-pulmonary MRI detects and quantifies treatment response after a single BPA treatment session.
KEY POINTS: • Two months after BPA regional parenchymal pulmonary perfusion (PBF) increased in the total lung parenchyma (p = 0.005), the treated lobes (p < 0.0001) and non-treated lobes (p = 0.015). • The PBF treatment changes in the treated lobe were significantly larger than in the non-treated lobes (p = 0.0049). • Change in NT proBNP, MRI-derived mean pulmonary artery pressure, pulmonary transit time, full width at half maximum, right ventricular (RV) ejection fraction, RV stroke volume, cardiac output, ventricular mass index and PBF in the non-treated lobes correlated with PBF change in the treated lobe (p < 0.05).
引用
- Schoenfeld C, Hinrichs JB, Olsson KM, et al. Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients. Eur Radiol. 2018. PMID: 30311032. doi:10.1007/s00330-018-5696-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。